ATE209643T1 - HETEROCYCLIC COMPOUNDS FOR PAIN TREATMENT AND USE THEREOF - Google Patents

HETEROCYCLIC COMPOUNDS FOR PAIN TREATMENT AND USE THEREOF

Info

Publication number
ATE209643T1
ATE209643T1 AT96921855T AT96921855T ATE209643T1 AT E209643 T1 ATE209643 T1 AT E209643T1 AT 96921855 T AT96921855 T AT 96921855T AT 96921855 T AT96921855 T AT 96921855T AT E209643 T1 ATE209643 T1 AT E209643T1
Authority
AT
Austria
Prior art keywords
alkyl
pct
independently
heteroatom
sec
Prior art date
Application number
AT96921855T
Other languages
German (de)
Inventor
John Dimaio
Dilip M Dixit
Original Assignee
Shire Biochem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Biochem Inc filed Critical Shire Biochem Inc
Application granted granted Critical
Publication of ATE209643T1 publication Critical patent/ATE209643T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/08Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/16Eight-membered rings
    • C07D313/20Eight-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/16Eight-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PCT No. PCT/CA96/00467 Sec. 371 Date Mar. 25, 1998 Sec. 102(e) Date Mar. 25, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/03978 PCT Pub. Date Feb. 6, 1997Polycyclic alkaloids of formula (I), wherein R1 is H, C1-6 alkyl, or C6-12 aryl optionally substituted with polar groups; R2 and R3 are independently H, OH, C1-6 alkyl, -C(NH)-NH2, a positively charged group, or C7-13 aralkyl optionally substituted with NH2, OH, C1-6 alkyl, or halogen; or R2 and R3 together form a 5 to 6 member ring optionally incorporating a heteroatom; R4is H, C1-6 alkyl, OR6, SR6 or N(R6)2, wherein each R6 is independently H, C1-3 alkyl; X is O, S, SO, SO2, N-R5, or C-(R5)2, wherein each R5 is independently H, C1-6 alkyl, or C7-13 aralkyl optionally interrupted with one or more heteroatom; n is an integer from 0 to 2; m is an integer from 0 to 3; with the proviso that when X is CH2 then R1 is not CH3, R2 and R3 are not both H, R4 is not OH, m is not 3 and n is not 0. For the treatment of pain and pharmaceutically acceptable compositions comprising those compounds. The compounds of this invention acts as agonists at the opiate receptor.
AT96921855T 1995-07-14 1996-07-12 HETEROCYCLIC COMPOUNDS FOR PAIN TREATMENT AND USE THEREOF ATE209643T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514417.6A GB9514417D0 (en) 1995-07-14 1995-07-14 Novel heterocyclic compounds for the treatment of pain and use thereof
PCT/CA1996/000467 WO1997003978A1 (en) 1995-07-14 1996-07-12 Novel heterocyclic compounds for the treatment of pain and use thereof

Publications (1)

Publication Number Publication Date
ATE209643T1 true ATE209643T1 (en) 2001-12-15

Family

ID=10777657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921855T ATE209643T1 (en) 1995-07-14 1996-07-12 HETEROCYCLIC COMPOUNDS FOR PAIN TREATMENT AND USE THEREOF

Country Status (17)

Country Link
US (1) US6054474A (en)
EP (1) EP0850234B1 (en)
JP (1) JPH11509211A (en)
CN (1) CN1196053A (en)
AT (1) ATE209643T1 (en)
AU (1) AU708504B2 (en)
BR (1) BR9609548A (en)
CA (1) CA2223646A1 (en)
DE (1) DE69617444T2 (en)
EA (1) EA001185B1 (en)
ES (1) ES2167577T3 (en)
FI (1) FI974609A7 (en)
GB (1) GB9514417D0 (en)
HU (1) HUP9900350A3 (en)
NO (1) NO980144L (en)
NZ (1) NZ311612A (en)
WO (1) WO1997003978A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153345A1 (en) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituted 1H-quinoxalin-2-one compounds and substituted 4-aryl and 4-heteroarylcyclohexane compounds
US6881829B2 (en) * 2002-04-26 2005-04-19 Chimeracom, L.L.C. Chimeric hybrid analgesics
CN108210933B (en) * 2016-12-22 2021-05-04 北京键凯科技股份有限公司 Conjugate of dezocine and polyethylene glycol
EP3919472A4 (en) * 2019-02-02 2022-11-09 Yangtze River Pharmaceutical Group Co., Ltd. Dezocine derivative and medical use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3836670A (en) * 1971-11-19 1974-09-17 American Home Prod Benzobicycloalkane amines for inducing analgesia
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
IL114715A (en) * 1989-02-27 1997-01-10 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes

Also Published As

Publication number Publication date
EA001185B1 (en) 2000-12-25
DE69617444D1 (en) 2002-01-10
NO980144D0 (en) 1998-01-13
FI974609A0 (en) 1997-12-23
JPH11509211A (en) 1999-08-17
HUP9900350A3 (en) 1999-11-29
FI974609L (en) 1998-01-14
EP0850234B1 (en) 2001-11-28
NZ311612A (en) 1999-05-28
FI974609A7 (en) 1998-01-14
NO980144L (en) 1998-01-13
CN1196053A (en) 1998-10-14
EP0850234A1 (en) 1998-07-01
WO1997003978A1 (en) 1997-02-06
BR9609548A (en) 1999-03-02
CA2223646A1 (en) 1997-02-06
AU708504B2 (en) 1999-08-05
US6054474A (en) 2000-04-25
GB9514417D0 (en) 1995-09-13
DE69617444T2 (en) 2002-08-01
ES2167577T3 (en) 2002-05-16
HUP9900350A2 (en) 1999-06-28
EA199800062A1 (en) 1998-08-27
AU6296896A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
HUP9801435A2 (en) 1-phenylpyrazole-3-carboxamides acting on neurotensin receptors, process for producing them and pharmaceutical compositions containing them
UA49847C2 (en) Imidazole derivatives HAVING affinity for a2 receptors, PHARMACEUTICAL COMPOSITION AND CURING METHOD
MX9206499A (en) DERIVATIVES OF ACICLICA ETILENDIAMINA
DE69328975D1 (en) AMINOMETHYLENE SUBSTITUTED HETEROCYCLIC COMPOUNDS AND THEIR USE AS ALSO SUBSTANCE P ANTAGONISTS
ATE243680T1 (en) TRI-SUBSTITUTED PHENYL DERIVATIVES USABLE AS PDE IV INHIBITORS
HUP0302475A2 (en) A method for treating allergies using substituted pyrazoles
ATE30021T1 (en) INDOLINONE-(2) DERIVATIVES, PROCESS FOR THEIR MANUFACTURE, PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS AND INTERMEDIATE PRODUCTS.
ATE172460T1 (en) 3-BENZOYLBENZOFURAN DERIVATIVES AS THYROID HORMONE ANTAGONISTS
ATE87308T1 (en) 3-ARYLURACILE FOR WEED CONTROL.
DE69106532D1 (en) N-SUBSTITUTED LACTAME AS CHOLECYSTOKININ ANTAGONISTS.
ATE163928T1 (en) BASIC DERIVATIVES OF GLUTAMIC ACID AND ASPARAGIC ACID AS GASTRIN OR CHOLECYSTOKININ ANTAGONISTS
MX9302178A (en) PEPTIDE COMPOUNDS.
DE68904342D1 (en) CYCLIC AMIDES.
NZ334736A (en) Acylaminoalkenylene-amide derivatives useful in treatments of the respiratory diseases where it is more specific for NK1 than NK2
DE69617444D1 (en) HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF PAIN AND THE USE THEREOF
PT874841E (en) 1-BENZENESULFONYLPYRROLIDINE DERIVATIVES AS BRADIQUININ RECEPTOR ANTAGONISTS
ES8702365A1 (en) PROCEDURE TO PREPARE NEW BENZAZEPINE DERIVATIVES.
GB9514448D0 (en) Novel heterocyclic NMDA-receptor antagonists
MX9800281A (en) Novel heterocyclic compounds for the treatment of pain and use thereof.
PL1603877T3 (en) NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS
FR2703679B1 (en) NOVEL PERHYDROISOINDOLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties